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Summary
Physalis peruviana is an Andean specie whose fruits are eaten as food and also has 
been reported in Colombian folk medicine for diabetes mellitus treatment. In addi-
tion, previous pharmacological studies on diabetic Wistar rats, an extract of P. peru-
viana fruits has been showed antidiabetic activity. In order to deepen in P. peruviana 
action mode as antidiabetic, in this investigation were determinate the Inhibitory 
Concentrations 50 (IC50) of P. peruviana fruits crude extract on alpha glucosidase 
from S. cerevisiae and from intestinal rat powder, on maltase and alpha amylase 
enzymes. The kinetic behavior of the extract on each enzyme was also investigated, 
and the enzyme constant (Km) and maximum rate (Vmax) were determined. 
Extract of fruits of P. peruviana showed different IC50 for alpha glucosidase from 
S. cerevisiae and intestinal rat powder, suggesting greater affinity for the enzyme of 
mammalian source (4114.7 and 3552.7 µg/mL, respectively). For maltase, the IC50 
was close to that obtained for alpha glucosidase (4191.0 µg/mL) while for alpha 
amylase, the extract exhibited the highest inhibition (IC50: 619.9 g/mL). Regarding 
kinetic behavior, the extract showed competitive inhibition on alpha-glucosidase 
and maltase, and on the non-competitive type of alpha amylase. These suggest that 
inhibition of intestinal carbohydrases is one of the modes of action for the antidia-
betic activity of fruits of P. peruviana.
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Resumen
Evaluación in vitro del efecto de un extracto de frutos de Physalis 
peruviana sobre algunas carbohidrasas intestinales
Physalis peruviana es una especie andina, cuyos frutos además de ser usados como 
alimento, son empleados en la medicina tradicional para el tratamiento de la diabetes 
mellitus. Además, estudios farmacológicos previos en ratas Wistar han demostrado 
actividad antidiabética de extractos de frutos de P. peruviana. Con el fin de profun-
dizar en el modo de acción de la actividad antidiabética de los frutos de P. peruviana, 
en la presente investigación se determinó la concentración inhibitoria 50 (CI50) del 
extracto crudo de frutos de P. peruviana, sobre las enzimas alfa glucosidasa obtenida 
de S. cerevisiae y de polvo intestinal de rata, maltasa y alfa amilasa. El comporta-
miento cinético del extracto sobre cada una de las enzimas también fue investigado 
y la constante enzimática (Km) y la velocidad máxima (Vmax) fueron determi-
nadas. El extracto de frutos de P. peruviana, mostró diferentes valores de CI50 para 
alfa glucosidasa obtenida de S. cerevisiae y para la obtenida de polvo intestinal de 
rata, sugiriendo una mayor afinidad por la enzima de origen mamífero (4114,7 and 
3552,7 µg/mL, respectivamente). Para maltasa la CI50 fue cercana a la obtenida para 
alfa glucosidasa (4191,0 µg/mL), mientras para alfa amilasa, el extracto presentó 
la mayor inhibición (CI50: 619,9 g/mL). Respecto al comportamiento cinético, el 
extracto mostró inhibición de tipo competitiva sobre alfa glucosidasa y maltasa y no 
competitiva sobre alfa amilasa. Los resultados sugieren que la inhibición de carbohi-
drasas intestinales es uno de los modos de acción de los frutos de P. peruviana como 
agente antidiabético.
Palabras clave: Physalis peruviana, carbohidrasas intestinales, alfa glucosidasa, alfa 
amilasa, maltasa.
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Introduction
Diabetes Mellitus Type II is a metabolic disorder characterized by permanent hyper-
glycemia, which is caused by defects in the secretion or action of insulin. Chronic 
hyperglycemia is associated with damage, dysfunction and failure of various organs 
[1]. Currently, there are different treatments for diabetes mellitus type II, including 
changes in lifestyle, use of oral hypoglycemic drugs or biotechnology products, and 
pancreatic transplants [2].
However, it has recently been shown that plants play an important role in health care. 
The World Health Organization has estimated that approximately 80% of the popu-
lation in emerging countries make regular use of traditional medicine (mostly derived 
from plants) and primary health care. Traditional medicine also plays an important 
role in the health care of the remaining 20% of the populations of the emerging econo-
mies and some developed countries [3].
The use of plants for medicinal purposes comes from our native communities, where it 
is passed down from generation to generation; a transmission of knowledge known as 
ethnomedicine. However, we cannot ignore the scientific and technological advances 
that have led to a better understanding of the behavior of nature, and it is essential to 
rigorously investigate the so-called medicinal plants, to determine their safety 
and effectiveness.
One of the plants used in traditional medicine for the treatment of diabetes mellitus is 
P. peruviana, commonly known as “uchuva”. In addition to its ethnopharmacological 
use, its fruits have shown in vivo antidiabetic activity, lowering blood glucose levels and 
some markers of oxidative stress [4].
There are different possible modes of action for antidiabetic drugs; one of them is 
the inhibition of enzymes necessary for polysaccharide digestion (these enzymes are 
also called carbohydrases). They are present in the intestinal villi, and participate in 
the cleavage of polysaccharides, which are converted into monosaccharides (glucose, 
fructose, galactose). The inhibition of this enzyme slows carbohydrate absorption and 
decreases postprandial blood glucose levels in both normal and diabetic subjects [2]. 
In recent years, many researchers have focused on the search for medicinal plants that 
inhibit carbohydrases [5-7], finding valuable information, particularly on plants with 
the presence of flavonoids, polyphenols and sugar derivatives [8]. Since fruits of P. 
peruviana have these secondary metabolites [9-11] the hypoglycemic effect may be due 
to inhibition of intestinal carbohydrases such as was reported by Pinto et al., 2009 who 
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found that fruits of P. peruviana inhibited the alpha amylase and alpha glucosidase 
enzymes [11]. Thus, the aim of this study was to deepen in the evaluation of in vitro 
inhibition of the extract of fruits of P. peruviana on some intestinal carbohydrases and 
identify the type of inhibition as possible mode for its hypoglycemic action.
Methods and materials
Materials
Alpha-glucosidase derived from Saccharomyces cerevisiae (S. cerevisiae) Sigma/Aldrich 
G5003, p-nitrophenyl-α-D-glucopyranoside (pNPG) Sigma/Aldrich N1377, Acar-
bose Sigma/Aldrich A8980, Maltose Sigma/Aldrich 63418, rat intestinal powder 
(from acetone) Sigma/Aldrich I1630, LiquiColor a commercial kit (Human GLLQ1), 
porcine pancreatic alpha-amylase (PPA) Sigma/Aldrich A3170, Blue Starch Sigma/
Aldrich S7776, and ethanolic extract of fruits of Physalis peruviana.
Plant material
The P. peruviana fruits were collected in February of 2012, directly by fruit traders 
from crops located in Granada-Cundinamarca, Colombia. The plant was identified 
and classified at the Herbario Nacional Colombiano – Universidad Nacional de 
Colombia and a voucher specimen was deposited in his collection under the code 
number (COL-574701). 
Preparation of the extract 
The ethanolic extract of fruits of P. peruviana used was prepared as follows: 400 g of 
fresh fruits were blended with 300 mL of 96% ethanol. The obtained juice was dryed in 
a circulant air oven at 40 °C for 24 hours. The resulting dry material was milled and was 
placed in a 2 L percolator to which 1500 mL of 96% ethanol was subsequently added. 
After 24 hours, the percolator was opened and the collected extract was concentrated 
in a rotary evaporator.
Total phenolic content
The total phenolic content were determined by using the Folin-Ciocalteu assay [12]. 
An aliquot (100 µL) of extracts or standard solution of gallic acid (3.13, 6.25, 12.5, 
25, and 50 μg/mL) was added to 2 mL tube. A reagent blank using distilled water was 
prepared. 100 µL of Folin-Ciocalteu phenol reagent 2N was added to the mixture and 
shaken. After 5 minutes 200 µL of 7.5% Na2CO3 solution was added to the mixture. 
The volume was then made up 2 mL with distilled water. After incubation for 120 
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minutes at room temperature, the absorbance against the reagent blank was determi-
ned at 726 nm with an UV-Visible spectrophotometer. Total phenolics content was 
expressed as mg Gallic Acid Equivalents (mg GA/ g of sample dry weight).
Inhibition of alpha glucosidase derived from S. cerevisiae
The alpha glucosidase inhibition activity was evaluated by measuring the release of 
p-nitrophenol from p-nitrophenyl-α-D-glucopyranoside (pNPG) following the 
method proposed by Pistia-Brueggemann, with slight modifications [13]. The assay 
contained 40 μL of phosphate buffer (0.5 M, pH 6.8); 10 μL of α-glucosidase (1 UI/
mL, derived from S. cerevisiae); 10 μL of pNPG (11.3 mM) and P. peruviana extract or 
acarbose (positive control) in a range of 20 to 10240 μg/mL. The absorbance was read 
after incubation for 45 minutes at 37 °C in a BioRad microplate spectrophotometer 
reader at 550 to 415nm. Alpha-glucosidase inhibitory activity was calculated accor-
ding to equation 1.
Inhibition %( )=
( )−( ){ }− −
100x
A A A ABackground Blank Sample Blank
A ABackground Blank−( )
 (1)
Where ABackground, ABlank and ASample are defined as the absorbance of 100% enzyme acti-
vity (only the solvent with the enzyme), the blank (the test sample without the enzyme) 
and the test sample (with the enzyme) respectively.
Inhibition of alpha glucosidase extracted from rat intestinal powder
The reaction mixture of this test was conducted under the same test conditions as those 
described in the previous section, changing only the source of alpha-glucosidase, which 
was obtained from acetone extract of rat intestine, according to previous works [14, 
15]. Briefly, 100 mg of rat intestinal powder was suspended in 1 mL of NaCl (0.9%) 
and sonicated twelve times for 30 seconds at 4 °C. After centrifugation (15000 rpm, 
30 min, 4 °C) the supernatant was used for the following tests. The alpha-glucosidase 
inhibitory activity was calculated according to equation 1.
Inhibition of maltase
Inhibition of maltase was performed by measuring the release of glucose by the Glu-
cose Oxidase-peroxidase method [16, 17] with slight modifications. The assay con-
tained 40 μL of phosphate buffer (0.5 M, pH 6.8); 10 μL of maltase obtained from 
acetone extract from rat intestine (1 UI/mL); 10 μL of maltose (7.5 mM) and 10 μL 
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of the extract of P. peruviana or Acarbose (positive control) in a range of 20 to 10240 
μg/mL. The absorbance was read after incubation at 37 °C for 45 minutes in a spec-
trophotometer with a microplate reader at 540 nm (BIORAD XMark). The maltase 
inhibitory activity was calculated according to equation 1.
Inhibition of alpha-amylase
The alpha-amylase inhibition activity was performed following the methodology 
based on the hydrolysis of starch covalently linked to Remazol Brilliant Blue [18], des-
cribed by Hansawasdi-Kawabata [19] with slight modifications. For the assay, 200µL 
of Remazol Brilliant Blue (10 mg/mL) was boiled for 5 min. Next, 100 µL of Tris-HCl 
buffer (0.05 M, pH 6.9 with calcium chloride 0.01 M), 100 µL of porcine pancreatic 
alpha-amylase (PPA, 2.1 IU/ml) and 200 µL of extract of P. peruviana or Acarbose 
(positive control) in a range of 20 to 10240 μg/mL were added. Absorbance was read 
after incubation at 37 °C for one hour at 595 nm, using a TECAN GENios spectro-
photometer. The alpha-amylase inhibitory activity was calculated according to equa-
tion 1. All inhibitory concentrations 50 (IC50) were calculated using the GraphPad 
Prism version 5.00 for Windows software
Kinetic behavior of P. peruviana extract on the evaluated enzymes
The kinetic behavior of the extract of each enzyme was performed following the 
methodology described above, except that the substrate concentrations were varied, 
ranging from 2.2 mM to 16.9 mM. The concentration of the extract was held cons-
tant to 5120 μg/mL. The reaction was started by adding the enzyme, and the endpoint 
was read at 415 nm for alpha-glucosidase, 540 nm to 595 nm for maltase and alpha-
amylase at time intervals of 5 minutes for 20 min. The results were used to determine 
the enzyme constant (Km) and maximum rate (Vmax) [20, 21] using a linear regres-
sion according to Lineweaver-Burk model, in the GraphPad Prism version 5 for Win-
dows Software.
Statistics analysis
The results were expressed as the arithmetic mean values ± standard deviation or stan-
dard error of the mean, and were analyzed statistically by the Tukey test and analyzed 
by two-way ANOVA, followed by the Bonferroni test for multiple comparisons. The 
difference between the sample and the target was considered significant (*) when p 
< 0.05. The statistical calculations and graphs were processed using GraphPad Prism 
version 5 for Windows. 
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Results
Total phenolic content
Previous works have been demonstrated that P. peruviana fruits are rich in phenolic 
compounds. In this investigation, it was found that employed extract content 6.3 ± 0.8 
mg GAE/g extract, this content is less than that reported by other authors [11]. It can 
be explained since the solvent used in this investigation (ethanol 96%) is less polar that 
that the solvent used by Pinto et al. [11] (ethanol 12%).
Inhibitory activity of P. peruviana on alpha glucosidase, maltase and alpha amylase
The inhibition activities of P. peruviana on alpha glucosidase from S. cerevisiae and 
alpha glucosidase extracted from rat intestinal powder are showed in Figures 1 and 2 
respectively. The IC50 values found are reported in the Table 1. It is important to note 
that the IC50 of acarbose and P. peruviana extract on alpha glucosidase differ according 
to the source of the enzyme; it is lower when the enzyme is extracted from the 
intestinal powder.
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IC50: Inhibitory concentration 50 – S. cerevisiae: Saccharomyces cerevisiae – P. peruviana: Physalis 
peruviana. The IC50 are expressed as the mean and the confidence limits of 95%.
















Figure 1. Inhibitory activity of an extract of fruits of P. peruviana on alpha glucosidase from S. cere-

















Figure 2. Inhibitory activity of an extract of fruits of P. peruviana on alpha glucosidase from lyophilized 
rat intestinal powder. Results are expressed as mean ± SEM (n = 3). Inhibitors: Acarbosa and ethanolic 
extract of fruits P. peruviana.
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Figure 1. Inhibitory activity of an extract of fruits of P. peruviana on alpha glucosidase 
from S. cerevisiae. Results are expressed as mean ± SEM (n = 3). Inhibitors: Acarbosa 
and ethanolic extract of fruits P. peruviana.The inhibitory activity of the extract of P. 
peruviana on maltase is shown in Figure 3, and the IC50 value found is shown in Table 
1. The IC50 of acarbose on this enzyme is lower than on alpha glucosidase (less than 
half ) while the IC50 of P. peruviana extract is very close to that found on alpha glu-

















Figure 3. Inhibitory activity of an extract of fruits of P. peruviana on maltase. Results are expressed 
as mean ± SEM (n = 3). Inhibitors: Acarbosa and ethanolic extract of fruits P. peruviana.
For alpha amylase, the inhibitory activity of P. peruviana is shown in Figure 4. The IC50 
value is lower than that found on alpha glucosidase and maltase (Table 1); the lowest 
IC50 obtained was for P. peruviana. 
Kinetic behavior of P. peruviana extract on the evaluated enzymes 
The reaction rates of P. peruviana on alpha-glucosidase, maltase and alpha amylase are 
shown in Figures 5 to 7, and the kinetic parameters are presented in Table 2. P. peruvia-
na extract has a competitive-type behavior on inhibition of and maltase where the pre-
sence of the substrate reduces the inhibitory activity of the extract but not change the 
maximum rate while it was found a mixed type inhibition on alpha-glucosidase, since 
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the maximum rate (Vmax) is reduced and the enzyme constant (Km) is increased. Re-


















Figure 4. Inhibitory activity of an extract of fruits of P. peruviana on alpha amylase. Results are 
expressed as mean ± SEM (n = 3). Inhibitors: Acarbosa and ethanolic extract of fruits P. peruviana.
Table 2. Kinetic parameters of the inhibition of the extract from P. peruviana on the different enzymes.














Km 1.538 3.205 1.110 7.087 0.569 0.411
Vmax 
(mM/min) 0.011 0.007 0.009 0.009 0.008 0.004
Km/ Vmax 137.877 458.654 118.032 1098.512 71.526 115.707
Type of 
inhibition Mixed Competitive Non-Competitive
Vmax, Maximum rate – Km; kinetic constant.
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Without inhibitor P. peruviana
- 1.0 - 0.4
Figure 5. Reaction rate of alpha-glucosidase on pNPG in the presence and absence of the ethanolic 


















Without inhibitor P. peruviana
- 0.8- 1.0
Figure 6. Reaction rate of maltase on maltose in the presence and absence of ethanolic extract of 
fruits of P. peruviana.

















Without inhibitor P. peruviana
Figure 7. Reaction rate of alpha-amylase on azure starch in the presence and absence of the ethanolic 
extract of fruits of P. peruviana.
Discussion
Inhibitory activity of P. peruviana on alpha glucosidase, maltase and amylase
The IC50 found for P. peruviana on alpha glucosidase from S. cerevisiae (4.11mg / mL) 
was high but similar to the IC50 presented by other extracts of medicinal plants tra-
ditionally used as hypoglycemiants. For these plants, IC50 values have been reported 
ranging from 1.8 µg/mL for Punica granatum extract [22] to 17.2 mg/mL for extract 
of Andrographis paniculata Nees [23]. On the other hand, in spite of Pinto et al., not 
reported IC50 values, is possible to note that inhibitions near to 50% was achieve with 
concentration more than 10 mg/mL of P. peruviana fruits extract [11]. This concentra-
tion is higher than the IC50 finding in this investigations, beside the lower content of 
total phenolic compounds in our extract. These findings suggest that other compounds 
besides phenols could be responsible of the alpha glucosidase inhibition.
Previous works had reported that the most of the plant extracts have lower IC50 on 
alpha-glucosidase extracted from S. cerevisiea than on the enzyme extracted from mam-
malian intestine [24-26]. This is not the case with P. peruviana, which suggests that 
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this extract is more specific for mammalian intestinal enzymes. This fact is important 
because a plant extract capable of inhibiting the digestion of complex carbohydrates in 
the human gastrointestinal tract should show inhibition of the enzyme extracted from 
the mammal, not only the enzyme obtained from microorganisms, since the values 
reported for inhibition of alpha glucosidase obtained from microorganisms cannot be 
extrapolated to enzymes from mammalian intestine. 
This divergence may be due to the difference in binding site molecular recognition of 
enzymes. Thus, many inhib itors of alpha glucosidase from S. cerevisiae do not show 
inhibition on alpha glucosidase extracted from mammals [15, 27]. Some authors 
report that both acarbose and voglibose have high inhibitory effects of alpha glu-
cosidase in mammals, but no inhibitory activity against alpha glucosidase form S. 
cerevisiae [26, 27]. 
For the enzyme maltase on acarbose, a lower IC50 was found than on alpha glucosidase. 
This is because acarbose binds to the enzyme with higher affinity than the substrate 
itself [28]. In the case of the ethanolic extract of fruits of P. peruviana, the IC50 was 
not significantly different from the IC50 on alpha glucosidase. This may be because the 
extract has a large number of compounds that can bind to various proteins contained 
in the crude enzyme solution, making its binding less specific. This fact had also been 
reported in other extracts, such as Stichopus japonicus [29].
For alpha amylase, the IC50 values found were lower, suggesting that the extract of P. 
peruviana produces a strong inhibition of this enzyme, although P. peruviana IC50 was 
higher than acarbose IC50 (619.9 and 229.6 µg/mL, respectively). Similar to reported 
for alpha glucosidase, Pinto et al. found 65% as the maximum inhibition when it was 
tested P. peruviana extract at concentration of 50 mg/mL, almost 100 times more than 
the IC50 found in this investigation [11].
The strong inhibition of acarbose on alpha amylase and lack of digestion of starch [30, 
31] are related to some side effects such as flatulence and bloating, and diarrhea [15]. 
Thus, an extract that shows less inhibition on alpha amylase could minimize these side 
effects [25, 30].
Kinetic behavior of P. peruviana extract on the evaluated enzymes
The kinetic behavior of P. peruviana on maltose is consistent with the results obtained 
in the inhibition, since the extract behaved very similarly to acarbose, a drug that has a 
competitive type of inhibition of these enzymes. For alpha glucosidase, it was found a 
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mixed type inhibition such as it was reported for some flavonoids especially quercetin 
[32], a flavonoid described for Physalis peruviana fruits [11]. However, is important to 
note that non-competitive behavior is usually preferred, because this prevents the pre-
sence or absence of substrate from affecting the binding of the inhibitor to the enzyme, 
resulting in less interaction with meals [26, 33, 34].
Regarding to alpha amylase, the extract exhibited a non-competitive inhibition that 
may be related to structural differences due to the origins of the enzymes [35]. Another 
factor that may explain the combination of competitive and non-competitive inhibi-
tion on the evaluated enzymes presented by P. peruviana extract is the fact that the 
extract presents more than one inhibitor. Due to the presence of polyphenols, such as 
flavonoids, it is possible for one inhibitor to bind to the active region of alpha-glucosi-
dase and another to bind to the active region of alpha amylase. 
Flavonoids or phenolic compounds have been linked to the inhibition of alpha-gluco-
sidase and alpha-amylase [36], and plants with phytochemical studies that have repor-
ted the presence of these secondary metabolites, or for which biological studies have 
demonstrated antioxidant activity, are promising in inhibiting alpha-glucosidase and 
amylase. For fruits of P. peruviana, the presence of both flavonoids and other phenols 
has been reported [37], including quercetin, campferol and flavonols [38, 39]. Howe-
ver, the findings of this investigation suggested that not only phenolics compounds but 
others, could be responsible for the moderate inhibition on alpha glucosidase, and the 
high inhibition on alpha-amylase.
Conclusions
Ethanolic extract of fruits of P. peruviana has shown different responses to microbial 
alpha glucosidase (Type I) and alpha glucosidase extracted from rat intestinal powder 
(Type II). Likewise, ethanol extract of fruits of P. peruviana type shows competitive 
inhibition on alpha-glucosidase, and on the non-competitive type of alpha amylase.
Based on the results of this investigation, it is suggested that inhibition of intestinal 
carbohydrases is one of the modes of action by which the fruits of P. peruviana exert 
hypoglycemic and antidiabetic activity. 
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